Cargando…

Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis

Aims: Systemic light-chain (AL) amyloidosis is a multisystemic disorder leading to multiple organ dysfunction and mortality that is often caused by cardiac involvement. Soluble suppression of tumorigenicity 2 (sST2) is a novel biomarker identified for risk stratification of heart disease. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yang, Xiao, Ying, Liu, Yongtai, Fang, Quan, Tian, Zhuang, Li, Jian, Zhou, Daobin, Xie, Zhongpeng, Dong, Ruijia, Zhang, Shuyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855859/ https://www.ncbi.nlm.nih.gov/pubmed/33553254 http://dx.doi.org/10.3389/fcvm.2020.597472

Ejemplares similares

Electrocardiogram Characteristics and Prognostic Value in Light-Chain Amyloidosis: A Comparison With Cardiac Magnetic Resonance Imaging
por: Guo, Xinli, et al.
Publicado: (2021)

Prognostic value of interleukin-33, sST2, myeloperoxidase, and matrix metalloproteinase-9 in acute aortic dissection
por: Jia, Yu, et al.
Publicado: (2023)

Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Zhang, Tianyi, et al.
Publicado: (2021)

Prognostic Value of sST2 in Heart Failure
por: Sciatti, Edoardo, et al.
Publicado: (2023)

Sex and age differences in sST2 in cardiovascular disease
por: Beetler, Danielle J., et al.
Publicado: (2023)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Cardiovascular toxicity from therapies for light chain amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2023)

The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients
por: Yue, Xiuzheng, et al.
Publicado: (2022)

Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

Corrigendum: Prognostic implication of longitudinal changes of left ventricular global strain after chemotherapy in cardiac light chain amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

Diagnostic and Prognostic Values of Cardiopulmonary Exercise Testing in Cardiac Amyloidosis
por: Banydeen, Rishika, et al.
Publicado: (2022)

Light-Chain Amyloidosis With Peripheral Neuropathy as an Initial Presentation
por: Qian, Min, et al.
Publicado: (2021)

The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis
por: Miao, Fujia, et al.
Publicado: (2023)

Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
por: Baker, Kelty R.
Publicado: (2022)

Prognostic Significance of Circulating Plasma Cells by Multi-Parametric Flow Cytometry in Light Chain Amyloidosis
por: Sidana, Surbhi, et al.
Publicado: (2018)

Grade 3 myocardial uptake in (99m)technetium-pyrophosphate scintigraphy in light chain cardiac amyloidosis
por: Okada, Atsushi, et al.
Publicado: (2021)

Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study
por: Liu, Xiao-hang, et al.
Publicado: (2022)

Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction
por: Xie, Hongyang, et al.
Publicado: (2020)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis
por: Ochs, Marco M., et al.
Publicado: (2017)

Clinical characteristics and prognostic value of renal immune complex deposition in patients with light chain amyloidosis
por: Yan, Jipeng, et al.
Publicado: (2022)

The prognostic value of sST2 and galectin-3 considering different aetiologies in non-ischaemic heart failure
por: Binas, David, et al.
Publicado: (2018)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
por: Stojkovic, Stefan, et al.
Publicado: (2020)

High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis
por: Li, Muzheng, et al.
Publicado: (2021)

A Risk Score to Diagnose Cardiac Involvement and Provide Prognosis Information in Patients at Risk of Cardiac Light-Chain Amyloidosis
por: Wu, Yan, et al.
Publicado: (2022)

The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis
por: Lin, Lu, et al.
Publicado: (2018)

Angiotensin Converting Enzyme Inhibitors (ACEIs) Decrease the Progression of Cardiac Fibrosis in Rheumatic Heart Disease Through the Inhibition of IL-33/sST2
por: Ambari, Ade M., et al.
Publicado: (2020)

Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis
por: Scheel, Paul J., et al.
Publicado: (2022)

Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis
por: Usuku, Hiroki, et al.
Publicado: (2023)

CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
por: Wang, Fangqing, et al.
Publicado: (2023)

Should we measure clonal circulating plasma cells in light chain amyloidosis?
por: Sidana, Surbhi, et al.
Publicado: (2018)

Short-Term Prognosis Value of sST2 for an Unfavorable Outcome in Hypertensive Patients
por: Farcaş, Anca Daniela, et al.
Publicado: (2020)

Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis
por: Bi, Xiao, et al.
Publicado: (2022)

Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Zhao, Li-Hong, et al.
Publicado: (2022)

High Serum Lactate Dehydrogenase adds Prognostic Value to Cardiac Biomarker Staging System for Light Chain Amyloidosis
por: He, Haiyan, et al.
Publicado: (2019)

Global epidemiology of amyloid light-chain amyloidosis
por: Kumar, Nishant, et al.
Publicado: (2022)

Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

Atypical immunoglobulin light chain amyloidosis: Spontaneous vertebral compression fracture, liver involvement, and bone marrow involvement report of 3 cases and review of the literature
por: Wu, Xia, et al.
Publicado: (2016)

Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis
por: Kim, Darae, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m5oigfl9sbc6op18g7n7b0bkl0